CLASSICAL HODGKIN LYMPHOMA
Clinical trials for CLASSICAL HODGKIN LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new CLASSICAL HODGKIN LYMPHOMA trials appear
Sign up with your email to follow new studies for CLASSICAL HODGKIN LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Immune cell therapy trial offers new hope for young hodgkin lymphoma patients
Disease control Not yet recruitingThis early-stage trial tests a new treatment for children, adolescents, and young adults with a certain type of Hodgkin lymphoma that has come back after initial therapy. The treatment uses the patient's own immune cells, which are modified in a lab to recognize and attack cancer…
Matched conditions: CLASSICAL HODGKIN LYMPHOMA
Phase: PHASE1 • Sponsor: New York Medical College • Aim: Disease control
Last updated Jun 09, 2026 12:09 UTC
-
New combo therapy targets tough hodgkin lymphoma in kids and young adults
Disease control Not yet recruitingThis study tests a new approach for children, teens, and young adults (ages 6 to 29) with poor-risk classical Hodgkin lymphoma that has not responded to standard treatments. Participants will receive strong chemotherapy, a stem cell transplant using their own cells, and then an i…
Matched conditions: CLASSICAL HODGKIN LYMPHOMA
Phase: PHASE1, PHASE2 • Sponsor: New York Medical College • Aim: Disease control
Last updated Jun 02, 2026 11:58 UTC